These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9781971)

  • 1. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation.
    O'Connor CM; Carson PE; Miller AB; Pressler ML; Belkin RN; Neuberg GW; Frid DJ; Cropp AB; Anderson S; Wertheimer JH; DeMets DL
    Am J Cardiol; 1998 Oct; 82(7):881-7. PubMed ID: 9781971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2).
    Packer M; Carson P; Elkayam U; Konstam MA; Moe G; O'Connor C; Rouleau JL; Schocken D; Anderson SA; DeMets DL;
    JACC Heart Fail; 2013 Aug; 1(4):308-314. PubMed ID: 24621933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE).
    Mozaffarian D; Nye R; Levy WC
    J Am Coll Cardiol; 2003 Jun; 41(11):1933-9. PubMed ID: 12798560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial.
    Carson PA; O'Connor CM; Miller AB; Anderson S; Belkin R; Neuberg GW; Wertheimer JH; Frid D; Cropp A; Packer M
    J Am Coll Cardiol; 2000 Aug; 36(2):541-6. PubMed ID: 10933370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
    Packer M; O'Connor CM; Ghali JK; Pressler ML; Carson PE; Belkin RN; Miller AB; Neuberg GW; Frid D; Wertheimer JH; Cropp AB; DeMets DL
    N Engl J Med; 1996 Oct; 335(15):1107-14. PubMed ID: 8813041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy is associated with lower mortality among patients with severe heart failure.
    Mozaffarian D; Nye R; Levy WC
    Am J Cardiol; 2004 May; 93(9):1124-9. PubMed ID: 15110204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine.
    Wijeysundera HC; Hansen MS; Stanton E; Cropp AS; Hall C; Dhalla NS; Ghali J; Rouleau JL;
    Am Heart J; 2003 Aug; 146(2):291-7. PubMed ID: 12891198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study.
    O'Connor CM; Radensky PW; Unger AN; Martin BC
    Clin Ther; 1999 Jul; 21(7):1254-65. PubMed ID: 10463522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
    Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRAISE (prospective randomized amlodipine survival evaluation) and criticism.
    Pfeffer MA; Skali H
    JACC Heart Fail; 2013 Aug; 1(4):315-317. PubMed ID: 24621934
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of death in heart failure. The Vasodilator-Heart Failure Trials. The V-HeFT VA Cooperative Studies Group.
    Goldman S; Johnson G; Cohn JN; Cintron G; Smith R; Francis G
    Circulation; 1993 Jun; 87(6 Suppl):VI24-31. PubMed ID: 8500236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
    Pitt B; Zannad F; Remme WJ; Cody R; Castaigne A; Perez A; Palensky J; Wittes J
    N Engl J Med; 1999 Sep; 341(10):709-17. PubMed ID: 10471456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation.
    Mohler ER; Sorensen LC; Ghali JK; Schocken DD; Willis PW; Bowers JA; Cropp AB; Pressler ML
    J Am Coll Cardiol; 1997 Jul; 30(1):35-41. PubMed ID: 9207618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic resistance predicts mortality in patients with advanced heart failure.
    Neuberg GW; Miller AB; O'Connor CM; Belkin RN; Carson PE; Cropp AB; Frid DJ; Nye RG; Pressler ML; Wertheimer JH; Packer M;
    Am Heart J; 2002 Jul; 144(1):31-8. PubMed ID: 12094185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
    Berl T; Hunsicker LG; Lewis JB; Pfeffer MA; Porush JG; Rouleau JL; Drury PL; Esmatjes E; Hricik D; Parikh CR; Raz I; Vanhille P; Wiegmann TB; Wolfe BM; Locatelli F; Goldhaber SZ; Lewis EJ;
    Ann Intern Med; 2003 Apr; 138(7):542-9. PubMed ID: 12667024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial.
    Nissen SE; Tuzcu EM; Libby P; Thompson PD; Ghali M; Garza D; Berman L; Shi H; Buebendorf E; Topol EJ;
    JAMA; 2004 Nov; 292(18):2217-25. PubMed ID: 15536108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
    N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amlodipine in heart failure: initial results of the PRAISE study].
    Steffen HM
    Herz; 1995 Aug; 20 Suppl 2():3-4. PubMed ID: 7557834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.